ESSA Pharma's market cap is currently $9.51M. The company's EPS TTM is $-0.09; its P/E ratio is ―; and it has a dividend yield of 840.45%. ESSA Pharma is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
